Antihistamines modestly reduce side effects of peanut oral immunotherapy

The use of H1 or H2 antihistamines may mitigate some side effects of peanut oral immunotherapy, but they did not influence quality of life, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Future trials should explore safer approaches to food allergy treatment that improve quality of life, Derek K. Chu, MD, PhD, of the department of medicine at McMaster University in Hamilton, Ontario, Canada, and colleagues wrote.
The randomized, three-arm, parallel-design, placebo-controlled Peanut Immunotherapy Starting in Canada, Evaluation and DiScovery, or

The use of H1 or H2 antihistamines may mitigate some side effects of peanut oral immunotherapy, but they did not influence quality of life, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Future trials should explore safer approaches to food allergy treatment that improve quality of life, Derek K. Chu, MD, PhD, of the department of medicine at McMaster University in Hamilton, Ontario, Canada, and colleagues wrote.
The randomized, three-arm, parallel-design, placebo-controlled Peanut Immunotherapy Starting in Canada, Evaluation and DiScovery, or